Abstract
(Int J Obstet Anesth. 2021;47:103187) Although neuraxial morphine is commonly administered to patients for analgesia following cesarean delivery (CD), one recognized side effect is respiratory depression. According to The Society for Obstetric Anesthesia and Perinatology (SOAP), obesity [body mass index (BMI) ≥40 kg/m2] is a condition which increases the odds for respiratory depression and therefore necessitates enhanced respiratory monitoring for patients receiving neuraxial morphine. However, limited research has been carried out on the relationship between respiratory depression and obesity. To improve guidelines for respiratory monitoring for this patient population, the authors compared rates of respiratory depression in postpartum women with BMI ≥40 kg/m2 to those of BMI <40 kg/m2. Specifically, the authors investigated the hypothesis that clinically significant respiratory depression following neuraxial morphine occurs more commonly in obese patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
